December 12, 2016 / 9:16 PM / 8 months ago

BRIEF-Peregrine Pharma Q2 loss per share $0.02

Dec 12 (Reuters) - Peregrine Pharmaceuticals Inc :

* Qtrly total revenue $23.4 million versus $9.5 million

* Peregrine Pharmaceuticals reports financial results for second quarter of fiscal year 2017 and recent developments

* Q2 loss per share $0.02

* Q2 earnings per share view $-0.03 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below